These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8980294)

  • 1. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin.
    Rhodes LE; Tsoukas MM; Anderson RR; Kollias N
    J Invest Dermatol; 1997 Jan; 108(1):87-91. PubMed ID: 8980294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
    Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
    Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo.
    Gerscher S; Connelly JP; Griffiths J; Brown SB; MacRobert AJ; Wong G; Rhodes LE
    Photochem Photobiol; 2000 Oct; 72(4):569-74. PubMed ID: 11045731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
    Choudry K; Brooke RC; Farrar W; Rhodes LE
    Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells.
    Bissonnette R; Zeng H; McLean DI; Korbelik M; Lui H
    Photochem Photobiol; 2001 Aug; 74(2):339-45. PubMed ID: 11547574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative model calculation of the time-dependent protoporphyrin IX concentration in normal human epidermis after delivery of ALA by passive topical application or lontophoresis.
    Star WM; Aalders MC; Sac A; Sterenborg HJ
    Photochem Photobiol; 2002 Apr; 75(4):424-32. PubMed ID: 12003134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microneedle pre-treatment of human skin improves 5-aminolevulininc acid (ALA)- and 5-aminolevulinic acid methyl ester (MAL)-induced PpIX production for topical photodynamic therapy without increase in pain or erythema.
    Mikolajewska P; Donnelly RF; Garland MJ; Morrow DI; Singh TR; Iani V; Moan J; Juzeniene A
    Pharm Res; 2010 Oct; 27(10):2213-20. PubMed ID: 20676735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
    Mikolajewska P; Iani V; Juzeniene A; Moan J
    Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
    Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
    Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A time course investigation of the fluorescence induced by topical application of 5-aminolevulinic acid and methyl aminolevulinate on normal human skin.
    Lesar A; Ferguson J; Moseley H
    Photodermatol Photoimmunol Photomed; 2009 Aug; 25(4):191-5. PubMed ID: 19614897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses.
    Fauteck JD; Ackermann G; Birkel M; Breuer M; Moor AC; Ebeling A; Ortland C
    Arch Dermatol Res; 2008 Feb; 300(2):53-60. PubMed ID: 17960406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
    Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model.
    Juzeniene A; Juzenas P; Iani V; Moan J
    Photochem Photobiol; 2002 Sep; 76(3):329-34. PubMed ID: 12403455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin.
    Wiegell SR; Stender IM; Na R; Wulf HC
    Arch Dermatol; 2003 Sep; 139(9):1173-7. PubMed ID: 12975159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester.
    Juzenas P; Sharfaei S; Moan J; Bissonnette R
    J Photochem Photobiol B; 2002 May; 67(1):11-7. PubMed ID: 12007462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.
    Kanick SC; Davis SC; Zhao Y; Sheehan KL; Hasan T; Maytin EV; Pogue BW; Chapman MS
    Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):561-6. PubMed ID: 26480810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
    Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
    Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice.
    van der Veen N; de Bruijn HS; Berg RJ; Star WM
    Br J Cancer; 1996 Apr; 73(7):925-30. PubMed ID: 8611408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracutaneous ALA photodynamic therapy: dose-dependent targeting of skin structures.
    Sakamoto FH; Doukas AG; Farinelli WA; Tannous Z; Su Y; Smith NA; Zurakowski D; Anderson RR
    Lasers Surg Med; 2011 Sep; 43(7):621-31. PubMed ID: 22057490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of elevating the skin temperature during topical ALA application on in vitro ALA penetration through mouse skin and in vivo PpIX production in human skin.
    van den Akker JT; Boot K; Vernon DI; Brown SB; Groenendijk L; van Rhoon GC; Sterenborg HJ
    Photochem Photobiol Sci; 2004 Mar; 3(3):263-7. PubMed ID: 14993942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.